Exchange: NYSEMkt·Updated 07:45 PM EDT
CVM logo

CVM Cel-Sci Corp

$1.56
$0.04
(2.50%)
Today
Closed $1.56
$0.065
(4.17%)
After Hours
Reported EarningsAug 17
Mkt Cap$27.44M
Vol170,341.00

About CVM

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.
26

Bearish Sentiment

How do you feel about CVM?

Advertisement|Remove ads.